Susan Hasty, Publisher
Table of Contents . . . November 10th, 1997
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Cancer Gene Therapy - Phase I-II Trial of Adv-Mediated IL-2 Adenocarcinoma Gene Therapy Initiated
Cancer Gene Therapy - Doctors Take Aim at Cancer With Magic Bullet
Chronic Granulomatous Disease - Study Advances Development of Gene Therapy for CGD
Conference Coverage (ICAAC) - Search For Elusive Genital Herpes Vaccine Continues
Dental Health - NIDR Supports Total Genome Studies of Major Oral Pathogens
Diabetes - Tiny Worms Hold Vital Clues for Treatment
Genetics - Cancer Before Age 50 May Indicate Increased BRCA1 or 2 Risk for Family Members
Hemophilia - Mini-Adenoviral Vector Effective in Hemophilia Gene Therapy Model
Industry News (Joint Venture) - Chinese Government Contract Awarded to Sequence Liver Cancer Gene
Inflammatory Disease - New Form Of Gene Therapy Holds Promise For The Future
Melanoma Vaccine (Clinical Trial) - Phase I Trial of Autologous Melanoma Vaccine Terminated
Nephronophithisis 1 (NPH1) - Gene Responsible for Hereditary Adolescent Kidney Disease Identified
Parkinson's Disease - Avigen Demonstrates Gene Therapy Success in Treating Animal Model of Disease
Renal Cell Carinoma - Hybrid Cell Vaccine Used to Treat Patients
Transplantation (Cornea) - Lab Cultures May Usher in New Era for Corneal Transplants
Vaccine Development - Studies Show Vaccine Technology Identifies Disease-Specific Epitopes
Vectors (Development) - HIV-Based Vector Sustains Efficient Gene Transfer into the Retina
Vectors (Development) - Plasmovirus Combines Viral and Nonviral Methods of Gene Transfer
Cancer Gene Therapy - "Sensitization of Human Cells to Lysis by Human Complement as an Approach for Cancer Gene Therapy."
Cancer Gene Therapy - "Telomerase Inhibition by Inducible Expression of Antisense RNA."
Cancer Immunotherapy - "Tumour Immunotherapy Using an Adenoviral Vector Expressing a Membrane Bound Mutant of Murine TNF."
DNA Vaccines (Antiviral) - "Effects of Immunization with HSV-2 Glycoprotein D2 DNA Formulated with Bupivacaine on Genital HSV Infection in Mice and Guinea Pigs."
DNA Vaccines (Chlamydia) - "DNA Vaccination With The MOMP Gene Induces Acquired Immunity to Chlamydia trachomatis (Mouse Pneumonitis) Infection."
DNA Vaccines (Immunology) - "DNA Immunization Circumvents the Defective Induction of Neonatal TH1 and CTL Responses Against Viral and Bacterial Antigens."
Genetics (Parasites) - "A Biochemical and Genetic Model for Parasite Antifolate Resistance."
Ribozyme Therapy - "Characterization of a c-erbB-2 Ribozyme in Ovarian Cancer Cells Using a Fusion Gene of c-erbB-2 and the Enhanced Green Fluorescent Protein."
Antisense Technology - "Ha-ras Mutations in N-nitrosomorpholine-Induced Lesions and Inhibition of Hepatocarcinogenesis by Antisense Sequences in Rat Liver."
Antisense Technology - "Increased Sensitivity of Gastric Cancer Cells to Natural Killer and Lymphokine-Activated Killer Cells by Antisense Suppression of N-acetylgalactosaminyltransferase."
Antisense Technology - "Making (Anti)sense of Non-Coding Sequence Conservation."
Cancer Gene Therapy - "Adenovirus-Mediated Transduction of Ribozymes Abrogates HER-2/neu and Pleiotrophin Expression and Inhibits Tumor Cell Proliferation."
Gene Delivery - "Bacterial beta-Galactosidase and Human Dystrophin Genes Are Expressed in Mouse Skeletal Muscle Fibers after Ballistic Transfection."
HIV Gene Therapy - "Construction of a Novel Virus That Targets HIV-1-Infected Cells and Controls HIV-1 Infection."
Liver Gene Therapy - "In vivo Distribution and Gene Expression of Genetically Modified Hepatocytes after Intrasplenic Transplantation."
Vectors - "Development of High-Titer Retroviral Producer Cell Lines by using Cre-Mediated Recombination."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.